Clopidogrel Versus Aspirin For The Treatment Of Acute Coronary Syndrome After A 12-Month Dual Antiplatelet Therapy- A Cost-Effectiveness Analysis From China Payer’s Perspective
May 1, 2018, 00:00
10.1016/j.jval.2018.04.364
https://www.valueinhealthjournal.com/article/S1098-3015(18)30664-8/fulltext
Title :
Clopidogrel Versus Aspirin For The Treatment Of Acute Coronary Syndrome After A 12-Month Dual Antiplatelet Therapy- A Cost-Effectiveness Analysis From China Payer’s Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30664-8&doi=10.1016/j.jval.2018.04.364
First page :
Section Title :
Open access? :
No
Section Order :
1223